Cancer Care Ontario | Cancer Care Ontario

1911 Results

ColonCancerCheck Abnormal Result Letter (Participant Without a Doctor)

Guidelines and Advice

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Status: Current
ID: 7-13
Version: 2

Updated

Sep 2025

Guidelines and Advice

Laparoscopic Surgery for Cancer of the Colon

Status: Archived
ID: 2-20-2

Sep 2005

ColonCancerCheck Abnormal Result Letter (Participant With Doctor)

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Ontario Cancer Profiles

Guidelines and Advice

Models of Care for Cancer Survivorship

Status: Current
ID: 26-1
Version: 2

Mar 2017

Guidelines and Advice

Follow-up Care for Survivors of Lymphoma who have Received Curative-Intent Treatment

Status: Current
ID: 26-5

Apr 2016

Diego Llovet

Scientist, Cancer Screening – Program Design, Acute and Hospital-Based Care, Ontario Health Behavioural Scientistdiego.llovet@ontariohealth.ca

Ontario Lung Screening Program Frequently Asked Questions for Healthcare Providers

Guidelines and Advice

Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Melanoma

Status: Current
ID: 8-1
Version: 6

Mar 2024

Guidelines and Advice

Molecular Analyses in the Diagnosis, Prognosis, and Selection of Therapy in non-GIST Soft Tissue Sarcomas

Status: Archived
ID: GL 11-12

Apr 2018

ColonCancerCheck Abnormal Result Letter (Participant Without a Doctor)

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Laparoscopic Surgery for Cancer of the Colon

ColonCancerCheck Abnormal Result Letter (Participant With Doctor)

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Ontario Cancer Profiles

Models of Care for Cancer Survivorship

Follow-up Care for Survivors of Lymphoma who have Received Curative-Intent Treatment

Diego Llovet

Ontario Lung Screening Program Frequently Asked Questions for Healthcare Providers

Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Melanoma

Molecular Analyses in the Diagnosis, Prognosis, and Selection of Therapy in non-GIST Soft Tissue Sarcomas

Pages